Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil treatment in Eisenmenger patients with pulmonary arterial hypertension
2007-002774-64Phase 3Terminated
- Sponsor
- Deutsches Herzzentrum der Charité
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sildenafil in pulmonary arterial hypertension (PAH) and Eisenmenger syndrome (2 arms), sponsored by Deutsches Herzzentrum der Charité. Primary endpoints: Change in 6-minute walk distance, Change in oxygen saturation and 1 more. Started Aug 2007; status: terminated.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)Eisenmenger syndrome
Beyond the preview
Go deeper on 2007-002774-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002774-64.